Reduction in curie score in neuroblastoma patients treated with naxitamab.

被引：0
|
作者：
Mora, Jaume
Chan, Godfrey Chi-Fung
Morgenstern, Daniel A.
Amoroso, Loredana
Nysom, Karsten
Faber, Joerg
Wingerter, Arthur
Bear, Melissa
Rubio-San-Simon, Alba
Kushner, Brian H.
Tornoe, Karen
Christensen, Rene DePont
机构：
[1] Hosp San Juan Dios, Pediat Canc Ctr Barcelona, Barcelona, Spain
[2] Univ Hong Kong, Hong Kong Childrens Hosp, Hong Kong, Peoples R China
[3] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[4] IRCCS Ist Giannina Gaslini, Genoa, Italy
[5] Univ Hosp Rigshosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark
[6] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Mainz, Germany
[7] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN USA
[8] Hosp Infantil Univ Nino Jesus, Madrid, Spain
[9] Mem Sloan Kettering Canc Ctr, New York, NY USA
[10] YmAbs Therapeut Inc, Horsholm, Denmark
[11] YmAbs AS, Horsholm, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10042
引用
收藏
页数：1
相关论文
共 50 条
  • [1] REDUCTION IN BONE METASTASES AND CURIE SCORE IN PATIENTS TREATED WITH NAXITAMAB IN TRIAL 201
    Kushner, Brian
    Chan, Godfrey
    Morgenstern, Daniel
    Amoroso, Loredana
    Nysom, Karsten
    Faber, Jörg
    Wingerter, Arthur
    Bear, Melissa
    Simon, Alba Rubio San
    De Las Heras, Blanca Martinez
    Tornoe, Karen
    Sorensen, Per Settergren
    Mora, Jaume
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S94 - S95
  • [2] Disease control in patients treated with naxitamab for refractory/relapsed high-risk neuroblastoma
    Mora, Jaume
    Chan, Godfrey C.
    Morgenstern, Daniel A.
    Amoroso, Loredana
    Nysom, Karsten
    Faber, Joerg
    Wingerter, Arthur
    Bear, Melissa
    Rubio-San-Simon, Alba
    Tornoe, Karen
    Koep, Sharif
    During, Maria
    Kushner, Brian H.
    CANCER RESEARCH, 2024, 84 (17)
  • [3] Patterns of improvement following initial response in patients treated with naxitamab for relapsed/refractory high-risk neuroblastoma
    Mora, Jaume
    Chan, Godfrey C.
    Morgenstern, Daniel A.
    Amoroso, Loredana
    Nysom, Karsten
    Faber, Joerg
    Wingerter, Arthur
    Bear, Melissa
    Rubio-San-Simon, Alba
    Tornoe, Karen
    Duering, Maria
    Kushner, Brian H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] NAXITAMAB EFFICACY AND SAFETY IN PATIENTS TREATED WITH AND WITHOUT STEROID PREMEDICATION
    Mora, Jaume
    Chan, Godfrey Chi Fung
    Morgenstern, Daniel
    Nysom, Karsten
    Faber, Joerg
    Wingerter, Arthur
    Bear, Melissa
    Rubio San Simon, Alba
    Kushner, Brian
    Tornoe, Karen
    Christensen, Rene
    Amoroso, Loredana
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [5] NEW TREATMENTS, NEW CHALLENGES: NEPHROTOXICITY ASSOCIATED WITH NAXITAMAB IN HIGH-RISK NEUROBLASTOMA PATIENTS
    Gorostegui, Maite
    Munoz-Perez, Juan Pablo
    Aguilar-Rodriguez, Ana Cristina
    Sancho, Pedro Arango
    Izurieta, Ana Carolina
    Mora, Jaume
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [6] Response Assessment of 131I-mIBG-therapy in high-risk neuroblastoma patients: SIOPEN or Curie score
    Schmidt, M. C.
    Plum, G.
    Gecht, J.
    Berthold, F.
    Hero, B.
    Drzezga, A.
    Simon, T.
    Decarolis, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S590 - S590
  • [7] New treatments, new challenges: nephrotoxicity associated to naxitamab in patients with high-risk neuroblastoma
    Arango Sancho, Pedro
    Aguilar Rodriguez, Ana Cristina
    Lopez Espinoza, Yarima
    Fortes Marin, Emma
    Munoz Perez, Juan Pablo
    Gorostegui Obanos, Maite
    Calzada Banos, Yolanda
    Lopez Baez, Victor Alfonso
    Jimenez Moreno, Marta
    Codina Sampera, Elena
    Madrid Aris, Alvaro
    Mora, Jaume
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1857 - I1857
  • [8] NEW TREATMENTS, NEW CHALLENGES: NEPHROTOXICITY ASSOCIATED TO NAXITAMAB IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Aguilar Rodriguez, Ana Cristina
    Arango Sancho, Pedro
    Munoz Perez, Juan Pablo
    Gorostegui Obanos, Maite
    Izurieta Pacheco, Ana Carolina
    Codina Sampera, Elena
    Jimenez Moreno, Marta
    Calzada Banos, Yolanda
    Jimenez Garcia, Raquel
    Gomez Herrera, Bernat
    Madrid Aris, Alvaro
    Mora, Jaume
    PEDIATRIC NEPHROLOGY, 2023, 38 : S104 - S105
  • [9] New treatments, new challenges: nephrotoxicity associated to naxitamab in patients with high-risk neuroblastoma
    Sancho, Pedro Arango
    Rodriguez, Ana Cristina Aguilar
    Espinoza, Yarima Lopez
    Marin, Emma Fortes
    Perez, Juan Pablo Munoz
    Obanos, Maite Gorostegui
    Banos, Yolanda Calzada
    Baez, Victor Alfonso Lopez
    Moreno, Marta Jimenez
    Sampera, Elena Codina
    Aris, Alvaro Madrid
    Mora, Jaume
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [10] PATTERN OF RELAPSE IN HIGH-RISK NEUROBLASTOMA (HR-NB) PATIENTS CONSOLIDATED WITH NAXITAMAB
    Rodriguez, Amalia Varo
    Vallejo, Elena Soques
    Gorostegui, Maite
    Zallo, Laura Andres
    Munoz Perez, Juan Pablo
    Heredia, Alicia Castaneda
    Mora, Jaume
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S231 - S231
12345